Medindia
Medindia LOGIN REGISTER
Advertisement

Intercell AG Announces Q1 2011 Results and Updates on R&D Progress

Wednesday, May 11, 2011 General News
Advertisement
Significant increase in IXIARO®/JESPECT® sales compared to Q1 2010

Key Financial Figures

EUR in thousands

3 months endedMarch 31,

Year ended

Dec. 31,

2011

2010

2010

Revenues

5,692

4,756

34,215

Net loss

(11,257)

(14,702)

(255,182)

Net operating cash flow

(23,453)

(15,468)

(65,120)

Cash and marketable securities, end of period

87,697

158,216

86,182

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close